EVI2B is a downstream target of CCAAT/enhancer binding protein alpha (C/EBPα), playing an important role in myeloid differentiation and the function of hematopoietic progenitors, thereby contributing to the onset of leukemia, consistent with our findings that the expression of EVI2B was highest in mature granulocytes [44]. This evidence concerns the gene CEBPA and leukemia.